Alkaloid Analogs

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 April 2014) | Viewed by 156885

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL, USA
Interests: organic/medicinal chemistry; drug discovery and development; anti-cancer and anti-infective agents; synthesis of marine natural products and their analogs; structure based drug design; SAR studies and lead optimization
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine alkaloid
  • analog
  • synthesis
  • cytotoxic
  • anticancer
  • anti-inflammatory
  • antibacterial
  • antimalarial
  • antiviral
  • Indole
  • Imidazole
  • pyrrole
  • carboline
  • quinoline
  • isoquinoline
  • carbazole
  • pyrroloquinoline
  • quinone
  • pyrroloquinone
  • pyrroloiminoquinone

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (12 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

637 KiB  
Article
Modification of Marine Natural Product Ningalin B and SAR Study Lead to Potent P-Glycoprotein Inhibitors
by Chao Yang, Iris L. K. Wong, Wen Bin Jin, Tao Jiang, Larry M. C. Chow and Sheng Biao Wan
Mar. Drugs 2014, 12(10), 5209-5221; https://doi.org/10.3390/md12105209 - 17 Oct 2014
Cited by 12 | Viewed by 8191
Abstract
In this study, new marine ningalin B analogues containing a piperazine or a benzoloxy group at ring C have been synthesized and evaluated on their P-gp modulating activity in human breast cancer and leukemia cell lines. Their structure-activity relationship was preliminarily studied. Compounds [...] Read more.
In this study, new marine ningalin B analogues containing a piperazine or a benzoloxy group at ring C have been synthesized and evaluated on their P-gp modulating activity in human breast cancer and leukemia cell lines. Their structure-activity relationship was preliminarily studied. Compounds 19 and 20 are potent P-gp inhibitors. These two synthetic analogues of permethyl ningalin B may be potentially used as effective modulators of P-gp-mediated drug resistance in cancer cells. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

834 KiB  
Article
Chronic Toxicity Study of Neosaxitoxin in Rats
by Ramiro J. Zepeda, Manila Candiracci, Nicolas Lobos, Sebastian Lux and Hugo F. Miranda
Mar. Drugs 2014, 12(9), 5055-5071; https://doi.org/10.3390/md12095055 - 25 Sep 2014
Cited by 9 | Viewed by 7793
Abstract
Neosaxitoxin (NeoSTX) is a specific reversible blocker of voltage gated sodium channels on excitable cells. In the last decade, it has been tested in a number of interesting clinical trials, however there is still little information available on mammalian toxicity. Rats were treated [...] Read more.
Neosaxitoxin (NeoSTX) is a specific reversible blocker of voltage gated sodium channels on excitable cells. In the last decade, it has been tested in a number of interesting clinical trials, however there is still little information available on mammalian toxicity. Rats were treated for 12 weeks with doses of 1, 3 or 6 μg/kg of subcutaneous NeoSTX. At weeks 12 and 17, animals were sacrificed and blood samples collected for hematological and biochemical analysis. Organs were harvested for weight determination and histopathological assessments. The lowest acute toxicity via the intraperitoneal (ip) route was (30.35 μg/kg) and there was no significant difference between intramuscular and subcutaneous routes (11.4 and 12.41 μg/kg). The NeoSTX adiministration did not produce lethality at week 12 and after five weeks of suspension. NeoSTX 6 μg/kg ip produced reductions (p < 0.05) in body weight and food intake, and increased blood level of total and direct bilirubin, GGT and SGOT at week 12; all of these were reversed in the recovery period. NeoSTX 1 and 3 μg/kg ip did not show significant changes with the control group. Histopathological presentations were normal in all groups. This study revealed that NeoSTX is safe in vivo, giving a reliable security margin for its use like a local anesthetic. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

589 KiB  
Communication
Tricyclic Guanidine Alkaloids from the Marine Sponge Acanthella cavernosa that Stabilize the Tumor Suppressor PDCD4
by Tanja Grkovic, Johanna S. Blees, Magdalena M. Bayer, Nancy H. Colburn, Cheryl L. Thomas, Curtis J. Henrich, Megan L. Peach, James B. McMahon, Tobias Schmid and Kirk R. Gustafson
Mar. Drugs 2014, 12(8), 4593-4601; https://doi.org/10.3390/md12084593 - 21 Aug 2014
Cited by 17 | Viewed by 6959
Abstract
A cell-based high-throughput screen that assessed the cellular stability of a tumor suppressor protein PDCD4 (Programmed cell death 4) was used to identify a new guanidine-containing marine alkaloid mirabilin K (3), as well as the known compounds mirabilin G ( [...] Read more.
A cell-based high-throughput screen that assessed the cellular stability of a tumor suppressor protein PDCD4 (Programmed cell death 4) was used to identify a new guanidine-containing marine alkaloid mirabilin K (3), as well as the known compounds mirabilin G (1) and netamine M (2). The structures of these tricyclic guanidine alkaloids were established from extensive spectroscopic analyses. Compounds 1 and 2 inhibited cellular degradation of PDCD4 with EC50 values of 1.8 μg/mL and 2.8 μg/mL, respectively. Mirabilin G (1) and netamine M (2) are the first marine natural products reported to stabilize PDCD4 under tumor promoting conditions. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

870 KiB  
Article
Synthesis and Biological Evaluation of Novel 3-Alkylpyridine Marine Alkaloid Analogs with Promising Anticancer Activity
by Alessandra Mirtes Marques Neves Gonçalves, Aline Brito De Lima, Maria Cristina Da Silva Barbosa, Luiz Fernando De Camargos, Júlia Teixeira De Oliveira, Camila De Souza Barbosa, José Augusto Ferreira Perez Villar, André Carvalho Costa, Isabella Viana Gomes da Silva, Luciana Maria Silva, Fernando De Pilla Varotti, Fabio Vieira Dos Santos and Gustavo Henrique Ribeiro Viana
Mar. Drugs 2014, 12(8), 4361-4378; https://doi.org/10.3390/md12084361 - 31 Jul 2014
Cited by 18 | Viewed by 7131
Abstract
Cancer continues to be one of the most important health problems worldwide, and the identification of novel drugs and treatments to address this disease is urgent. During recent years, marine organisms have proven to be a promising source of new compounds with action [...] Read more.
Cancer continues to be one of the most important health problems worldwide, and the identification of novel drugs and treatments to address this disease is urgent. During recent years, marine organisms have proven to be a promising source of new compounds with action against tumoral cell lines. Here, we describe the synthesis and anticancer activity of eight new 3-alkylpyridine alkaloid (3-APA) analogs in four steps and with good yields. The key step for the synthesis of these compounds is a Williamson etherification under phase-transfer conditions. We investigated the influence of the length of the alkyl chain attached to position 3 of the pyridine ring on the cytotoxicity of these compounds. Biological assays demonstrated that compounds with an alkyl chain of ten carbon atoms (4c and 5c) were the most active against two tumoral cell lines: RKO-AS-45-1 and HeLa. Micronucleus and TUNEL assays showed that both compounds are mutagenic and induce apoptosis. In addition, Compound 5c altered the cellular actin cytoskeleton in RKO-AS-45-1 cells. The results suggest that Compounds 4c and 5c may be novel prototype anticancer agents. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

744 KiB  
Article
Action of Clathrodin and Analogues on Voltage-Gated Sodium Channels
by Steve Peigneur, Aleš Žula, Nace Zidar, Fiona Chan-Porter, Robert Kirby, David Madge, Janez Ilaš, Danijel Kikelj and Jan Tytgat
Mar. Drugs 2014, 12(4), 2132-2143; https://doi.org/10.3390/md12042132 - 4 Apr 2014
Cited by 9 | Viewed by 6830
Abstract
Clathrodin is a marine alkaloid and believed to be a modulator of voltage-gated sodium (NaV) channels. Since there is an urgent need for small molecule NaV channel ligands as novel therapeutics, clathrodin could represent an interesting lead compound. Therefore, clathrodin [...] Read more.
Clathrodin is a marine alkaloid and believed to be a modulator of voltage-gated sodium (NaV) channels. Since there is an urgent need for small molecule NaV channel ligands as novel therapeutics, clathrodin could represent an interesting lead compound. Therefore, clathrodin was reinvestigated for its potency and NaV channel subtype selectivity. Clathrodin and its synthetic analogues were subjected to screening on a broad range of NaV channel isoforms, both in voltage clamp and patch clamp conditions. Even though clathrodin was not found to exert any activity, some analogues were capable of modulating the NaV channels, hereby validating the pyrrole-2-aminoimidazole alkaloid structure as a core structure for future small molecule-based NaV channel modulators. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Figure 1

237 KiB  
Article
Two New Tryptamine Derivatives, Leptoclinidamide and (-)-Leptoclinidamine B, from an Indonesian Ascidian Leptoclinides dubius
by Hiroyuki Yamazaki, Defny S. Wewengkang, Teruaki Nishikawa, Henki Rotinsulu, Remy E. P. Mangindaan and Michio Namikoshi
Mar. Drugs 2012, 10(2), 349-357; https://doi.org/10.3390/md10020349 - 10 Feb 2012
Cited by 12 | Viewed by 7833
Abstract
Two new tryptamine-derived alkaloids, named as leptoclinidamide (1) and (-)-leptoclinidamine B (2), were isolated from an Indonesian ascidian Leptoclinides dubius together with C2-α-D-mannosylpyranosyl-L-tryptophan (3). The structure of 1 was assigned on the basis of spectroscopic [...] Read more.
Two new tryptamine-derived alkaloids, named as leptoclinidamide (1) and (-)-leptoclinidamine B (2), were isolated from an Indonesian ascidian Leptoclinides dubius together with C2-α-D-mannosylpyranosyl-L-tryptophan (3). The structure of 1 was assigned on the basis of spectroscopic data for 1 and its N-acetyl derivative (4). Compound 1 was an amide of tryptamine with two β-alanine units. Although the planar structure of 2 is identical to that of the known compound (+)-leptoclinidamine B (5), compound 2 was determined to be the enantiomer of 5 based on amino acid analysis using HPLC methods. Compounds 1 to 4 were evaluated for cytotoxicity against two human cancer cell lines, HCT-15 (colon) and Jurkat (T-cell lymphoma) cells, but none of the compounds showed activity. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

1277 KiB  
Article
Expression, Purification and Bioactivities Analysis of Recombinant Active Peptide from Shark Liver
by Zhengbing Lv, Yu Ou, Qian Li, Wenping Zhang, Boping Ye and Wutong Wu
Mar. Drugs 2009, 7(2), 258-267; https://doi.org/10.3390/md7020258 - 22 Jun 2009
Cited by 13 | Viewed by 10586
Abstract
The Active Peptide from Shark Liver (APSL) was expressed in E. coli BL21 cells. The cDNA encoding APSL protein was obtained from shark regenerated hepatic tissue by RT-PCR, then it was cloned in the pET-28a expression vector. The expressed fusion protein was purified [...] Read more.
The Active Peptide from Shark Liver (APSL) was expressed in E. coli BL21 cells. The cDNA encoding APSL protein was obtained from shark regenerated hepatic tissue by RT-PCR, then it was cloned in the pET-28a expression vector. The expressed fusion protein was purified by Ni-IDA affinity chromatography. SDS-PAGE and HPLC analysis showed the purity of the purified fusion protein was more than 98%. The recombinant APSL (rAPSL) was tested for its biological activity both in vitro, by its ability to improve the proliferation of SMMC7721 cells, and in vivo, by its significant protective effects against acute hepatic injury induced by CCl4 and AAP (acetaminophen) in mice. In addition, the rAPSL could decrease the blood glucose concentration of mice with diabetes mellitus induced by alloxan. Paraffin sections of mouse pancreas tissues showed that rAPSL (3 mg/kg) could effectively protect mouse islets from lesions induced by alloxan, which indicated its potential application in theoretical research and industry. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Review

Jump to: Research

415 KiB  
Review
New One-Pot Methodologies for the Modification or Synthesis of Alkaloid Scaffolds
by Amir E. Wahba and Mark T. Hamann
Mar. Drugs 2010, 8(8), 2395-2416; https://doi.org/10.3390/md8082395 - 24 Aug 2010
Cited by 23 | Viewed by 11914
Abstract
There are several avenues by which promising bioactive natural products can be produced in sufficient quantities to enable lead optimization and medicinal chemistry studies. The total synthesis of natural products is an important, but sometimes difficult, approach and requires the development of innovative [...] Read more.
There are several avenues by which promising bioactive natural products can be produced in sufficient quantities to enable lead optimization and medicinal chemistry studies. The total synthesis of natural products is an important, but sometimes difficult, approach and requires the development of innovative synthetic methodologies to simplify the synthesis of complex molecules. Various classes of natural product alkaloids are both common and widely distributed in plants, bacteria, fungi, insects and marine organisms. This mini-review will discuss the scope, mechanistic insights and enantioselectivity aspects of selected examples of recently developed one-pot methods that have been published in 2009 for the synthesis of substituted piperidines, quinolizidines, pyrrolidines, hexahydropyrrolizines, octahydroindolizines and g-lactams. In addition, progress on the synthesis of b-carboline (manzamine) alkaloids will also be discussed. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

380 KiB  
Review
Neurotoxic Alkaloids: Saxitoxin and Its Analogs
by Maria Wiese, Paul M. D’Agostino, Troco K. Mihali, Michelle C. Moffitt and Brett A. Neilan
Mar. Drugs 2010, 8(7), 2185-2211; https://doi.org/10.3390/md8072185 - 20 Jul 2010
Cited by 623 | Viewed by 36745
Abstract
Saxitoxin (STX) and its 57 analogs are a broad group of natural neurotoxic alkaloids, commonly known as the paralytic shellfish toxins (PSTs). PSTs are the causative agents of paralytic shellfish poisoning (PSP) and are mostly associated with marine dinoflagellates (eukaryotes) and freshwater cyanobacteria [...] Read more.
Saxitoxin (STX) and its 57 analogs are a broad group of natural neurotoxic alkaloids, commonly known as the paralytic shellfish toxins (PSTs). PSTs are the causative agents of paralytic shellfish poisoning (PSP) and are mostly associated with marine dinoflagellates (eukaryotes) and freshwater cyanobacteria (prokaryotes), which form extensive blooms around the world. PST producing dinoflagellates belong to the genera Alexandrium, Gymnodinium and Pyrodinium whilst production has been identified in several cyanobacterial genera including Anabaena, Cylindrospermopsis, Aphanizomenon Planktothrix and Lyngbya. STX and its analogs can be structurally classified into several classes such as non-sulfated, mono-sulfated, di-sulfated, decarbamoylated and the recently discovered hydrophobic analogs—each with varying levels of toxicity. Biotransformation of the PSTs into other PST analogs has been identified within marine invertebrates, humans and bacteria. An improved understanding of PST transformation into less toxic analogs and degradation, both chemically or enzymatically, will be important for the development of methods for the detoxification of contaminated water supplies and of shellfish destined for consumption. Some PSTs also have demonstrated pharmaceutical potential as a long-term anesthetic in the treatment of anal fissures and for chronic tension-type headache. The recent elucidation of the saxitoxin biosynthetic gene cluster in cyanobacteria and the identification of new PST analogs will present opportunities to further explore the pharmaceutical potential of these intriguing alkaloids. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

349 KiB  
Review
Alkaloids in Marine Algae
by Kasım Cemal Güven, Aline Percot and Ekrem Sezik
Mar. Drugs 2010, 8(2), 269-284; https://doi.org/10.3390/md8020269 - 4 Feb 2010
Cited by 171 | Viewed by 22695
Abstract
This paper presents the alkaloids found in green, brown and red marine algae. Algal chemistry has interested many researchers in order to develop new drugs, as algae include compounds with functional groups which are characteristic from this particular source. Among these compounds, alkaloids [...] Read more.
This paper presents the alkaloids found in green, brown and red marine algae. Algal chemistry has interested many researchers in order to develop new drugs, as algae include compounds with functional groups which are characteristic from this particular source. Among these compounds, alkaloids present special interest because of their pharmacological activities. Alkaloid chemistry has been widely studied in terrestrial plants, but the number of studies in algae is insignificant. In this review, a detailed account of macro algae alkaloids with their structure and pharmacological activities is presented. The alkaloids found in marine algae may be divided into three groups: 1. Phenylethylamine alkaloids, 2. Indole and halogenated indole alkaloids, 3. Other alkaloids. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

175 KiB  
Review
Terpenyl-Purines from the Sea
by Marina Gordaliza
Mar. Drugs 2009, 7(4), 833-849; https://doi.org/10.3390/md7040833 - 23 Dec 2009
Cited by 39 | Viewed by 15136
Abstract
Agelasines, asmarines and related compounds are natural products with a hybrid terpene-purine structure isolated from numerous genera of sponges (Agela sp., Raspailia sp.). Some agelasine analogs and related structures have displayed high general toxicity towards protozoa, and have exhibited broad-spectrum antimicrobial activity [...] Read more.
Agelasines, asmarines and related compounds are natural products with a hybrid terpene-purine structure isolated from numerous genera of sponges (Agela sp., Raspailia sp.). Some agelasine analogs and related structures have displayed high general toxicity towards protozoa, and have exhibited broad-spectrum antimicrobial activity against a variety of species, including Mycobacterium tuberculosis, and also an important cytotoxic activity against several cancer cell lines, including multidrug-resistant ones. Of particular interest in this context are the asmarines (tetrahydro[1,4]diazepino[1,2,3-g,h]purines), which have shown potent antiproliferative activity against several types of human cancer cell lines. This review summarizes the sources of isolation, chemistry and bioactivity of marine alkylpurines and their bioactive derivatives. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

955 KiB  
Review
Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition
by Sébastien Deslandes, Stefan Chassaing and Evelyne Delfourne
Mar. Drugs 2009, 7(4), 754-786; https://doi.org/10.3390/md7040754 - 1 Dec 2009
Cited by 43 | Viewed by 13982
Abstract
Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial [...] Read more.
Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide. Full article
(This article belongs to the Special Issue Alkaloid Analogs)
Show Figures

Graphical abstract

Back to TopTop